MXRA5 and neoplasm: The estimated daily tumor growth, in mm3 per day, was calculated (using the described formula [53]) and results showed that aav-MXRA5-sh-S1 injection robustly inhibited priPC-1 xenograft growth in mice (Fig. 8B).